Trials / Withdrawn
WithdrawnNCT05233215
GROW (Glioma Specialists Reaching Out With Support) Support
GROW Support (Glioma Specialists Reaching Out With Support): Assessment of a Comprehensive Support Program for Low Grade Glioma Patients Post-treatment
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Dana-Farber Cancer Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This research study is being done to test a participant and caregiver-driven model of follow-up survivorship care,GROW Support (Glioma Specialists Reaching Out With Support), for post-treatment, low grade glioma patients.
Detailed description
This research study is a Feasibility Study, which examines if a supportive intervention for people with low grade gliomas (LGGs) and their caregivers is acceptable and feasible to patients and their caregivers. The research study procedures include: screening for eligibility and study interventions including filling out questionnaires and virtual or in-clinic supportive follow up visits to identify additional supportive needs that may arise. Participants will be in this research study for up to 6 months. It is expected that about 40 people will take part in this research study. The Levitan-Zabin Fund for GROW Support is supporting this research study by providing funds for research team members to do this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | GROW (Glioma Specialists Reaching Out With Support) Support Program | Follow-up survivorship care plan for patients and caregivers |
Timeline
- Start date
- 2022-07-01
- Primary completion
- 2023-12-15
- Completion
- 2024-06-15
- First posted
- 2022-02-10
- Last updated
- 2023-01-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05233215. Inclusion in this directory is not an endorsement.